Ryan Guenette

All Posts

  • Wait! Before You Sell Your REIT Investments

    By Ryan Guenette - August 18, 2013 | Tickers: EQR, O, VTR

    Everything seems to be going wrong for REITs. The Vanguard REIT ETF is down nearly 20% from 2012 highs, however it may not be the ideal time to blow out of your REIT investments. It could even be an incredible opportunity for long-term minded investors.

    The Good Times Never Seemed So Good

    In May of this year, the REIT industry was rapidly approaching historic highs. The Vanguard REIT ETF, which more »

  • A Bust in Back-to-School Season Could Paralyze These Retailers

    By Ryan Guenette - August 8, 2013 | Tickers: ANF, ARO, AEO

    Teen apparel retailer American Eagle’s (NYSE: AEO) disappointing guidance  for its second-quarter financial results has set the stage for an eventful back-to-school season for all the players in the space, potentially having a major negative effect on your money.

    This eagle plummets

    In May 2013, American Eagle forecasted second-quarter earnings coming in between $0.19 and $0.21. After trading closed on Aug. 5, American Eagle surprisingly announced  that more »

  • The Debit Card Kingdom May Be Crumbling

    By Ryan Guenette - August 8, 2013 | Tickers: AXP, MA, V

    This article has been amended to better reflect the ramifications of the debit card ruling.

    A landmark ruling in a federal case regarding debit card fees could potentially cost the kings of plastic billions. When and if the hype materializes, which companies are standing to weather this financial storm, and come out the other side stronger? 

    The Judge Has Spoken

    On July 31, a U.S. district court invalidated a more »

  • Automakers' Bumpy Ride in the Land Down Under

    By Ryan Guenette - August 6, 2013 | Tickers: F, GM, TM

    Australia’s automotive manufacturing industry is growing weaker every day. The Australian government is determined to halt the market’s collapse, and has partnered with the largest automaker in the world to bring back jobs to the the land down under. But will these efforts be enough? 

    It All Started At the Top

    More than 400,000 vehicles were made in Australia in 2004, an all-time high.

    Eight years later more »

  • Out With the Old, In With the New in Treating MS

    By Ryan Guenette - July 31, 2013 | Tickers: BIIB, NVS, PFE, SNY, TEVA

    Hidden beneath all the numbers and metrics in Biogen Idec's (NASDAQ: BIIB) recent earnings report  is a key confirmation of a shifting market in the treatment of multiple sclerosis. This alteration could yield billions of dollars for companies positioned to take advantage of it. 

    What Happened

    On July 25, Biogen reported second-quarter financial results. Earnings of $2.30 per share and revenue of $1.7 billion both trumped estimates more »

  • Are the Golden Arches Falling?

    By Ryan Guenette - July 29, 2013 | Tickers: BKW, MCD, WEN, YUM

    The king of the fast-food industry recently released disappointing second-quarter financial results, confirming that the remainder of 2013 is likely to be unsatisfactory. Investors are now left with the question of what that news means to the entire industry and their money.

    What Happened

    On July 22, McDonald’s (NYSE: MCD) reported second-quarter financial results. Earnings of $1.38 per share came in $0.03 below the expected mark of more »

  • Who Should Investors Trust in the Scattered Online Travel Booking Industry?

    By Ryan Guenette - July 29, 2013 | Tickers: EXPE, OWW, PCLN, TRIP

    Over the past week, two of the most prominent companies in the online travel booking industry have reported second-quarter financial results. These reports sent one stock soaring 16%, and another plummeting almost 30%. With mixed signals coming from different companies, which perspective of the industry should investors trust?

    What Happened

    On July 24, TripAdvisor (NASDAQ: TRIP) reported second-quarter financial results, posting earnings of $0.46 per share, up 24% year more »

  • Soda Is Fizzling, Snacks Are Crunching, and Rumors Are Swirling

    By Ryan Guenette - July 26, 2013 | Tickers: KO, MDLZ, PEP

    Financial results released in the recent quarters by two titans in the food and beverage industries, and a bold proposal by activist investor Nelson Peltz, have made it crystal clear that the snack market is considerably outperforming the soda market. This fundamental trend could have a major effect upon these massive companies, as well as the entire snack and soda industries.

    What Has Happened 

    On July 17, Peltz, owner of more »

  • What Is the True Significance of This Federal Court Case?

    By Ryan Guenette - July 18, 2013 | Tickers: AMZN, AAPL, CBS, NWSA

    A federal judge ruled on Wednesday that Apple (NASDAQ: AAPL) “facilitated a conspiracy” in conjunction with major book publishers to pump up the price of e-books, and in turn cost consumers millions. Handed down by U.S. District Judge Denise Cote in Manhattan, the decision marks a significant victory for the U.S. government and may have implications in the digital media market. As Judge Cote called for a new more »

  • How Are These Tech Titans Affected By Alterations in the Smartphone Landscape?

    By Ryan Guenette - July 18, 2013 | Tickers: AAPL, BBRY, GOOG, MSFT

    On June 4, Comscore, a market-research company focused on technology markets, released data regarding the United States smartphone industry in the 3 months ending in April. According to the report, 138.5 million people owned smartphones in the U.S. during these three months, which is up 7% since January. This statistic represents 58% mobile market penetration.

    The report encompassed statistics regarding the market share accredited to the largest OEMs more »

  • Is This Gloomy Warning a Telltale Sign for the Medical Devices Industry?

    By Ryan Guenette - July 17, 2013 | Tickers: BAX, BDX, ISRG, MDT

    On July 9, Intuitive Surgical (NASDAQ: ISRG) warned of second-quarter financial results coming in at disappointing levels, although the company does not officially report until July 18.

    The company stated that it expects sales to come in at $575 million for the second quarter, nearly 9% south of the consensus of Wall Street analysts. Year over year, growth is still anticipated to top 7%; however, it will be the first more »

  • What Does This Monumental Milestone Mean For the Auto Industry?

    By Ryan Guenette - July 16, 2013 | Tickers: F, GM, TM

    China is now General Motors' (NYSE: GM) largest market. Even with the Chinese economy slowing considerably, General Motors posted a record Chinese half year sale statistic recently. Sales for the company in the region surged 10.6% during the first half of 2013 to almost 1.6 million vehicles, more than the 1.4 million vehicles sold in the US over the same time period. The 1.6 million vehicles more »

  • Has Multiple Myeloma Met its Match?

    By Ryan Guenette - July 16, 2013 | Tickers: CELG, JNJ, ONXX, SNY

    Multiple myeloma is a cancer of plasma cells, a type of white blood cell present in bone marrow. This cancer can lead to abnormally high calcium levels, kidney failure, bone damage, and anemia-related fatigue. However, broad advancements are being made in treating the disease and Celgene (NASDAQ: CELG)(NASDAQ: CELG)(NASDAQ: CELG) is leading the charge.

    In a late stage study, its flagship blood-cancer drug Revlimid, assisted in extending the time in which more »

  • Will the Chinese Economic Slowdown Spread to the Casinos of Macau?

    By Ryan Guenette - July 12, 2013 | Tickers: LVS, MPEL, MGM, WYNN

    Lying on the western side of the Pearl River Delta, bordering the Guangdong providence to the north, and facing the South China Sea to the east and south is the one of the two special administrative regions of the People’s Republic of China, Macau, also referred to as Macao.

    Formerly a Portuguese colony, Macau was governed by Portugal from the mid-16th century until 1999, when control of the more »

  • Can the PC Market Get Anything Right?

    By Ryan Guenette - July 5, 2013 | Tickers: AAPL, DELL, HPQ, INTC, MSFT

    The personal computer market can’t seem to get anything right. Research firm IHS iSuppli reported on June 27 that first-quarter shipments of notebook computers by original design manufacturers (ODMs) like Compal Electronics and Quanta, which are largely responsible for building the mainstream laptops, were worse than had been originally forecast. Shipments declined 17% from the prior quarter to 33.2 million units, plummeting 12% year-over-year.

    On April 10, it more »

  • Where Energy Meets Return

    By Ryan Guenette - July 2, 2013 | Tickers: ENB, EPD, KMP, OKS, TRP

    A trailblazing North American energy transportation and distribution company, Enbridge (NYSE: ENB), has been trounced year to date, declining 4.99% compared to the 12.42% return offered by the blue chip average.

    Enbridge transports and distributes energy across the United States and Canada. Operating a crude oil and liquids transportation system, Enbridge is additionally operating in the natural gas transmission and midstream businesses. Liquids pipelines, gas distribution, gas pipelines more »

  • How Should Investors Capitalize on the American Energy Boom?

    By Ryan Guenette - July 1, 2013 | Tickers: AWK, WTR, VE, XYL

    Let’s take a journey back to just after World War II. Nearly all major countries in the world are in shambles, and the country which is perceived to be the strongest, the United States, produces nearly 40% of the world’s goods. Present day, this measure has shrunk to roughly 18%.

    However, not all news is gloomy for the red, white, and blue. Right now as you read this more »

  • Is This Pharmaceutical Giant About To Lose Its Cornerstone Drug?

    By Ryan Guenette - July 1, 2013 | Tickers: ABBV, HSP, JNJ, PFE

    What’s the worst nightmare of all pharmaceutical companies? Generics. They might as well be the grim reaper in the eyes of the brand-name pharmaceuticals. Generics completely destroy the pricing power and monopoly one company possesses on a particular drug, costing that particular company billions in lost revenue. Just one example of the devastating effects generics have on the original patent holding company is displayed in the case of Lipitor more »

  • All Aboard the Rails in Search of Black Gold?

    By Ryan Guenette - July 1, 2013 | Tickers: BRK-B, CP, CSX, KSU, UNP

    The United States is pumping out more crude oil than the country’s pipelines can carry. The risk associated with oil drilling in the United States has disappeared, as a result of innovative technologies such as hydraulic fracking. The days of U.S. oil companies scouring the world for pools of reachable crude oil are over. Equipped with technologies such as fracking, the US oil industry has flourished and volumes more »

  • Is it Finally the Right Time to Take a Bite out of This Tech Titan?

    By Ryan Guenette - June 28, 2013 | Tickers: AMZN, AAPL, BBRY, GOOG, MSFT

    It has been a rough 2013 for Apple investors. While the Dow Jones Industrial Average has climbed 12.60%, Apple (NASDAQ: AAPL) has declined -24.48%. The 2013 year has been marked with a disappointing earnings report, an apparent lack of innovation, and a flurry of analyst downgrades, all of which have contributed to the share price seen today. With the company trading at levels not seen since 2011, is more »

  • Page 1 of 12